Are you a new member? Sign up now
Login area
| Sign up
close
BAVENCIO - 200mg/10ml - 1x10ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF04 | BioTech | Avelumab - 200mg/10ml | 10358 | 179019/1 | BAVENCIO | 200mg/10ml | 1x10ml | Injectable concentrate for solution | Infusion | Food & Drug Corporation FDC | Merck Serono SA | Switzerland | 97,176,574 L.L | 2.44 | E2 | Merck Serono SA | Switzerland | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FF04 | BioTech | Avelumab - 200mg/10ml | 10358/388 | 179019/1 | BAVENCIO | 200mg/10ml | 1x10ml | Injectable concentrate for solution | Infusion | Food & Drug Corporation FDC | Merck Serono SA | Switzerland | L.L | 2.44 | E2 | Merck Serono SA | Switzerland | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024